Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer

Here the authors identify retinoblastoma (RB) protein as an intrinsic inhibitor of BRD4 and demonstrate that loss of RB induces BRD4 cistrome changes in the genome and enrichment of GPCR-cAMP signaling pathway, conferring resistance to small molecule BET inhibitor.

Bibliographic Details
Main Authors: Donglin Ding, Rongbin Zheng, Ye Tian, Rafael Jimenez, Xiaonan Hou, Saravut J. Weroha, Liguo Wang, Lei Shi, Haojie Huang
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-34024-y
_version_ 1811336311540285440
author Donglin Ding
Rongbin Zheng
Ye Tian
Rafael Jimenez
Xiaonan Hou
Saravut J. Weroha
Liguo Wang
Lei Shi
Haojie Huang
author_facet Donglin Ding
Rongbin Zheng
Ye Tian
Rafael Jimenez
Xiaonan Hou
Saravut J. Weroha
Liguo Wang
Lei Shi
Haojie Huang
author_sort Donglin Ding
collection DOAJ
description Here the authors identify retinoblastoma (RB) protein as an intrinsic inhibitor of BRD4 and demonstrate that loss of RB induces BRD4 cistrome changes in the genome and enrichment of GPCR-cAMP signaling pathway, conferring resistance to small molecule BET inhibitor.
first_indexed 2024-04-13T17:37:34Z
format Article
id doaj.art-2d1d3c9ab3354c74b4af0e72ef46ad75
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-13T17:37:34Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-2d1d3c9ab3354c74b4af0e72ef46ad752022-12-22T02:37:17ZengNature PortfolioNature Communications2041-17232022-10-0113111510.1038/s41467-022-34024-yRetinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancerDonglin Ding0Rongbin Zheng1Ye Tian2Rafael Jimenez3Xiaonan Hou4Saravut J. Weroha5Liguo Wang6Lei Shi7Haojie Huang8Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and ScienceBasic and Translational Research Division, Department of Cardiology, Boston Children’s HospitalDepartment of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese MedicineDepartment of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and ScienceDivison of Oncology, Mayo Clinic College of Medicine and ScienceDivison of Oncology, Mayo Clinic College of Medicine and ScienceDivison of Medical Informatics and Statistics, Mayo Clinic College of Medicine and ScienceDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and ScienceDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and ScienceHere the authors identify retinoblastoma (RB) protein as an intrinsic inhibitor of BRD4 and demonstrate that loss of RB induces BRD4 cistrome changes in the genome and enrichment of GPCR-cAMP signaling pathway, conferring resistance to small molecule BET inhibitor.https://doi.org/10.1038/s41467-022-34024-y
spellingShingle Donglin Ding
Rongbin Zheng
Ye Tian
Rafael Jimenez
Xiaonan Hou
Saravut J. Weroha
Liguo Wang
Lei Shi
Haojie Huang
Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer
Nature Communications
title Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer
title_full Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer
title_fullStr Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer
title_full_unstemmed Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer
title_short Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer
title_sort retinoblastoma protein as an intrinsic brd4 inhibitor modulates small molecule bet inhibitor sensitivity in cancer
url https://doi.org/10.1038/s41467-022-34024-y
work_keys_str_mv AT donglinding retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT rongbinzheng retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT yetian retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT rafaeljimenez retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT xiaonanhou retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT saravutjweroha retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT liguowang retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT leishi retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer
AT haojiehuang retinoblastomaproteinasanintrinsicbrd4inhibitormodulatessmallmoleculebetinhibitorsensitivityincancer